Evolution Wealth Advisors, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.

Quarter-by-quarter ownership
Evolution Wealth Advisors, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2021$6,000
-62.5%
154
-60.1%
0.00%
-66.7%
Q2 2021$16,000
-11.1%
386
-7.0%
0.00%
-25.0%
Q1 2021$18,000
-18.2%
415
-7.2%
0.00%
-20.0%
Q4 2020$22,000
+37.5%
447
+16.7%
0.01%
+25.0%
Q3 2020$16,000
+77.8%
383
+101.6%
0.00%
+33.3%
Q2 2020$9,0001900.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2021
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders